Literature DB >> 8032936

Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat--study by 13P- and 1H-NMR spectroscopy.

T Aureli1, A Miccheli, M E Di Cocco, O Ghirardi, A Giuliani, M T Ramacci, F Conti.   

Abstract

The effects of acetyl-L-carnitine (ALCAR) treatment on brain energy state recovery and lactic acid levels following 20 min ischemia and 2, 24 and 48 h reperfusion were investigated by 31P and 1H-NMR spectroscopy. Transient forebrain ischemia was induced by four-vessel occlusion method in fed 6-month-old Fischer rats. ALCAR or saline was administered by intraperitoneal route immediately after 20 min ischemia and again at 1, 4, 24 and 30 h during reperfusion. Twenty-min severe forebrain ischemia was associated with a marked decrease in phosphocreatine (PCr) and ATP levels and a corresponding increase in lactic acid, inorganic phosphate (Pi), AMP, creatine, glycerol 3-phosphate and alanine levels. Following reperfusion, a general tendency to restore pre-ischemic metabolite levels was observed. However, after 2 h reperfusion in saline-treated rats, lactic acid and Pi levels remained significantly higher, while ATP levels were still significantly lower than in non-ischemic controls. On the contrary, in ALCAR-treated animals a complete recovery of all metabolites including Pi and ATP was observed, while PCr levels were even more elevated compared with those in saline-treated rats. Furthermore lactic acid content was significantly lower than that in both saline-treated and non-ischemic control rats. It is concluded that a potential therapeutic role may be claimed for ALCAR in the treatment of cerebral ischemia through mechanisms that include faster recovery and improvement of brain energy production as well as a decreased lactic acid content during early post-ischemic reperfusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032936     DOI: 10.1016/0006-8993(94)90013-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

2.  Induction of cell surface blebbing by increased cellular Pi concentration.

Authors:  M Marcussen
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

3.  Replies to commentaries on ATP changes during sleep.

Authors:  Markus Dworak; Robert W McCarley; Tae Kim; Anna V Kalinchuk; Radhika Basheer
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 4.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

Review 5.  Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

Authors:  Santina A Zanelli; Nina J Solenski; Robert E Rosenthal; Gary Fiskum
Journal:  Ann N Y Acad Sci       Date:  2005-08       Impact factor: 5.691

6.  Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain.

Authors:  Susanna Scafidi; Jennifer Racz; Julie Hazelton; Mary C McKenna; Gary Fiskum
Journal:  Dev Neurosci       Date:  2011-01-12       Impact factor: 2.984

7.  Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats.

Authors:  Shiyu Tang; Su Xu; Xin Lu; Rao P Gullapalli; Mary C McKenna; Jaylyn Waddell
Journal:  Dev Neurosci       Date:  2017-02-23       Impact factor: 2.984

8.  Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy.

Authors:  T Aureli; M E Di Cocco; G Capuani; R Ricciolini; C Manetti; A Miccheli; F Conti
Journal:  Neurochem Res       Date:  2000-03       Impact factor: 3.996

Review 9.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28

10.  CSPGs inhibit axon branching by impairing mitochondria-dependent regulation of actin dynamics and axonal translation.

Authors:  Rajiv Sainath; Andrea Ketschek; Leah Grandi; Gianluca Gallo
Journal:  Dev Neurobiol       Date:  2016-08-02       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.